3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
2
Terminated
1
Suspended
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Melanoma
23
Neoplasm Metastasis
14
Leukemia, Myeloid, Acute
11
Carcinoma, Renal Cell
10
Neoplasms
8
Kidney Neoplasms
8
Skin Neoplasms
5
Recurrence
5
Leukemia
5
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
5
Ovarian Neoplasms
4
Lymphoma, Non-Hodgkin
4
Colorectal Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Neuroblastoma
3
Lymphoma, Follicular
3
Congenital Abnormalities
3
Carcinoma
3
Uterine Cervical Neoplasms
2
Triple Negative Breast Neoplasms
2
Prostatic Neoplasms
2
Myelodysplastic Syndromes
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Head and Neck Neoplasms
2
Carcinoma, Merkel Cell
2
Interventions
Fluorouracil
17
Cisplatin
17
pembrolizumab
12
Radiotherapy
11
Oxaliplatin
10
Irinotecan
9
Paclitaxel
6
Leucovorin
6
Docetaxel
6
Carboplatin
6
Capecitabine
6
Neoadjuvant Therapy
5
Trastuzumab
4
Panitumumab
4
Gefitinib
4
Esophagectomy
4
Cyclophosphamide
4
Cetuximab
4
Surgical Procedures, Operative
3
Celecoxib
3
tegafur-gimeracil-oteracil
2
spartalizumab
2
sodium glycididazole
2
niraparib
2
fludarabine
2
S 1 (combination)
2
Plicamycin
2
Pemetrexed
2
Lapatinib
2
Gemcitabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Esophageal Neoplasms
×
Interleukin-2
×
Clear all
NCT01795976
2018-08-07
ATTACK-OG
The Christie NHS Foundation Trust
Phase 2
Terminated
2 enrolled